Epidemiology methods approaches experiences covid19
32308988 2020. The use of simulation to prepare and improve responses to infectious disease outbreaks like COVID-19: practical tips and resources from Norway, Denmark, and the UK
32282887 ä. Understanding the Dynamics of COVID-19
32334894 ä. A state overview of COVID19 spread, interventions and preparedness
32360746 2020. Weathering COVID-19 Storm: Successful Control Measures of Five Asian Countries
C7151256 ä. Community-based prevention and control of COVID-19: Experience from China
32301478 2020. Counting Coronavirus Disease 2019 (COVID-19) Cases: Case Definitions, Screened Populations and Testing Techniques Matter
32176272 ä. Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran
32150748 ä. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
32023340 ä. Reporting, Epidemic Growth, and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic
32259195 ä. Intersecting U S Epidemics: COVID-19 and Lack of Health Insurance
32343764 ä. Health Insurance Status and Risk Factors for Poor Outcomes With COVID-19 Among U S Health Care Workers: A Cross-sectional Study
32240293 ä. Collision of the COVID-19 and Addiction Epidemics
32240291 ä. When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis
32240283 ä. An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19
32298421 ä. Pandemic Surge Models in the Time of Severe Acute Respiratory Syndrome Coronavirus-2: Wrong or Useful?
32289150 2020. Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic
32175421 2020. Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis
32287518 2020. Rapid surveillance of COVID-19 in the United States using a prospective space-time scan statistic: Detecting and evaluating emerging clusters
32266703 ä. Why Only Test Symptomatic Patients? Consider Random Screening for COVID-19
32249361 ä. A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic
32362799 ä. Composite Monte Carlo decision making under high uncertainty of novel coronavirus epidemic using hybridized deep learning and fuzzy rule induction?
32331618 2020. COVID-19: Mitigation or suppression?
32331787 ä. Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates
32279479 2020. Asymptomatic Patients with Novel Coronavirus Disease (COVID-19)
32328220 ä. A Proposed Process for Risk Mitigation During the COVID-19 Pandemic
32327306 ä. New paths for sustainable solutions to tackle global and emerging infectious threats
32375234 2020. Temperature Decreases Spread Parameters of the New Covid-19 Case Dynamics
32182724 2020. Understanding Unreported Cases in the COVID-19 Epidemic Outbreak in Wuhan, China, and the Importance of Major Public Health Interventions
32342242 ä. Outbreak dynamics of COVID-19 in China and the United States
32188819 2020. Analysis of COVID-19 infection spread in Japan based on stochastic transition model
32321904 2020. Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up
32295793 2020. To monitor the COVID-19 pandemic we need better quality primary care data
32375776 2020. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK
32164708 2020. What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures?
C7154065 2020. Methodological challenges of analysing COVID-19 data during the pandemic
32331516 2020. Can mathematical modelling solve the current Covid-19 crisis?
32238182 2020. The fiscal value of human lives lost from coronavirus disease (COVID-19) in China
32341002 2020. Mitigating the wider health effects of covid-19 pandemic response
